Victory Capital Management
TTPH

Victory Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Victory Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,450
Closed -$4K – 3683
2020
Q1 		$4K Buy
+2,450
New +$5K ﹤0.01% 3602
2019
Q4 		– Sell
-459
Closed -$2K – 3662
2019
Q3 		$2K Buy
+459
New +$3.06K ﹤0.01% 3673
2016
Q3 		– Sell
-32
Closed -$3K – 1865
2016
Q2 		$3K Buy
32
+1
+3% +$92 ﹤0.01% 1628
2016
Q1 		$3K Buy
31
+3
+11% +$300 ﹤0.01% 1659
2015
Q4 		$6K Buy
28
+1
+4% +$200 ﹤0.01% 1671
2015
Q3 		$4K Buy
+27
New +$19.8K ﹤0.01% 1614

Other funds holding TTPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Victory Capital Management's TTPH Position: Q2 2020 in Review

Victory Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2020, closing a stake of 2,450 shares — an estimated $4K sold.

Victory Capital Management first reported a position in TTPH in Q3 2015 and held it in 6 quarters. The position peaked at $6K in Q4 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q2 2020.

  • Victory Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 2,450 Tetraphase Pharmaceuticals, Inc. shares in Q2 2020, an estimated $4K.
  • Victory Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 6 quarters.
  • Victory Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $6K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.